This website uses cookies to ensure you get the best experience on the website.If you continue to browse, then you agree to our Cookie Policy and Privacy Policy.
Clarivate is a leading global provider of transformative intelligence. They offer data, insights, and analytics to support innovation in various industries, including academia, government, life sciences, healthcare, and intellectual property. Their mission is to empower their customers to make informed decisions and drive breakthroughs in their respective fields.
One of the biggest challenges the pharma industry continues to face today is the failure of drug candidates due to unexpected adverse reactions. Late-stage clinical attrition for safety reasons represents a high risk in terms of patient safety and cost. Early anticipation of safety issues enables informed decisions.In this session we will present how OFF-X's analytic tools and curated data from a broad range of sources can help de-risk drug development.Agenda:Challenges the pharma industry continues to face today How the safety intelligence tool OFF-X can help de-risk drug developmentDrug - SemagacestatTarget – BTK inhibitorsTarget- 4-1BB activatorsSummaryQ&ASpeaker: Kinsi Oberoi, Senior Solution Consultant